Research - Zürich, Zurich, Switzerland
CellSpring develops blood-based tests for diagnosing early stage cancer. The tests rely on a proprietary exosomal biomarker discovery technology developed at world class research institutes in Switzerland. Detecting cancer early means catching it before a patient even has symptoms -- when the full gamut of therapeutic options is available and most likely to succeed.
Gmail
Google Apps